スルホンアミドの世界市場レポート 2025年

スルホンアミド市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.8％で37億9,000万米ドルに成長します。予測期間の成長は、併用療法に対する需要の高まり、抗菌薬耐性管理への関心の高まり、開発途上地域におけるヘルスケアアクセスの拡大、農業および畜産業における用途の拡大、スルホンアミド製剤に対する規制当局の支持的承認などに起因すると考えられます。予測期間における主な動向としては、ドラッグデリバリー技術の進歩、スルホンアミド誘導体の革新、標的抗菌療法の開発、抗菌剤の継続的な研究開発、創薬における人工知能の統合などが挙げられます。

皮膚感染症の蔓延がスルホンアミド市場の拡大を牽引すると予想されています。皮膚感染症は、皮膚に侵入した細菌、ウイルス、真菌、寄生虫によって引き起こされ、発赤、腫脹、疼痛、かゆみ、化膿などの症状を引き起こします。皮膚感染症の増加は、抗生物質耐性菌の増加によるところが大きく、一般的な感染症は治療が難しく、広がりやすくなっています。スルホンアミドは、細菌の増殖を阻害し、葉酸の合成を阻害することで、様々な感受性のある細菌に有効であり、皮膚感染症の治療に効果的です。例えば、2025年2月、米国を拠点とする非営利団体である米国皮膚科学会は、毎年約5,000万人の米国人がにきびに悩まされており、国内で最も一般的な皮膚疾患であると報告しています。その結果、皮膚感染症の有病率の増加がスルホンアミド市場の成長に拍車をかけています。

スルホンアミド市場の企業は、スルホンアミドベースの薬剤の治療用途を拡大し、希少な神経筋疾患におけるアンメットニーズに対応するため、原発性周期性麻痺（PPP）などの革新的な治療法の開発に注力しています。PPP療法は、血中カリウム濃度の変化によって筋力低下や麻痺のエピソードを引き起こす、まれな遺伝性神経筋疾患群を管理するためのものです。例えば、2024年5月、英国を拠点とする製薬会社サイクル・ファーマシューティカルズ・リミテッドは、低カリウム血症性周期性麻痺（HypoPP）、高カリウム血症性周期性麻痺（HyperPP）および類似疾患の患者に対する治療の選択肢として、ORMALVITM（ジクロルフェナミド）を発表しました。このFDA承認の治療薬は、カリウム濃度の変動に関連した筋力低下や麻痺を特徴とするこれらの遺伝性疾患に特化した治療を提供します。今回の上市の特筆すべき点は、サイクルの患者中心のアプローチであり、オーダーメイドのサポートサービスを通じてアクセシビリティとアドヒアランスの向上に重点を置いていることです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界スルホンアミド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のスルホンアミド市場：成長率分析
• 世界のスルホンアミド市場の実績：規模と成長, 2019-2024
• 世界のスルホンアミド市場の予測：規模と成長, 2024-2029, 2034F
• 世界スルホンアミド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のスルホンアミド市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口スルホンアミド
• 局所用スルホンアミド
• 注射用スルホンアミド
• 世界のスルホンアミド市場化学構造による、実績と予測, 2019-2024, 2024-2029F, 2034F
• スルファニルアミド
• スルファセタミド
• スルファメトキサゾール
• 世界のスルホンアミド市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗菌
• 抗真菌剤
• 抗ウィルス薬
• 利尿剤
• 抗糖尿病薬
• その他の用途
• 世界のスルホンアミド市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 調査室
• その他のエンドユーザー
• 世界のスルホンアミド市場経口スルホンアミドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• スルファメトキサゾール
• スルフィソキサゾール
• スルファジアジン
• スルファレン
• 世界のスルホンアミド市場、局所スルホンアミドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• スルファセタミドナトリウム
• スルファジアジン銀
• スルファミロン
• スルファジアジンクリーム
• 世界のスルホンアミド市場注射用スルホンアミドのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• スルファメトキサゾール
• スルファジアジンナトリウム
• スルファメトキシピリダジン

第7章 地域別・国別分析

• 世界のスルホンアミド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のスルホンアミド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• スルホンアミド市場：競合情勢
• スルホンアミド市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • Cadila Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Amneal Pharmaceuticals LLC
• Lupin Limited
• Bimeda Holdings PLC
• Fera Science Limited
• Virchow Laboratories Limited
• Hebei Veyong Bio-Chemical Co. Ltd.
• Interchemie Werken De Adelaar B.V.
• AdvaCare Pharma
• Manus Aktteva Biopharma LLP
• Suleshvari Pharma
• Shree Vardayini Chemical Industries Private Limited
• VetOne
• Zydus Cadila Healthcare Limited
• Mission Pharmacal Company
• Allegis Pharmaceuticals LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• スルホンアミド市場2029：新たな機会を提供する国
• スルホンアミド市場2029：新たな機会を提供するセグメント
• スルホンアミド市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sulfonamide refers to a group of synthetic antimicrobial agents containing the sulfonamide group, used to treat bacterial infections by inhibiting folic acid synthesis in microbes. These compounds were among the earliest antibiotics developed and remain in use today as part of combination therapies for various infections.

The main product types of sulfonamide include oral sulfonamides, topical sulfonamides, and injectable sulfonamides. Oral sulfonamides are antibiotics that contain the sulfonamide group (-SO2NH2) in their chemical structure. The key chemical structures include sulfanilamide, sulfacetamide, and sulfamethoxazole. Applications include antibacterial, antifungal, antiviral, diuretics, antidiabetic, and others, and they are used by various end users such as hospitals, clinics, research laboratories, and others.

The sulfonamide market research report is one of a series of new reports from The Business Research Company that provides sulfonamide market statistics, including the sulfonamide industry global market size, regional shares, competitors with the sulfonamide market share, detailed sulfonamide market segments, market trends, and opportunities, and any further data you may need to thrive in the sulfonamide industry. This sulfonamide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sulfonamide market size has grown strongly in recent years. It will grow from $2.72 billion in 2024 to $2.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the increasing prevalence of bacterial infections, growing availability of generic sulfonamide drugs, rising cost-effective treatment options, expanded use in veterinary medicine, and the expanding pharmaceutical manufacturing capacity.

The sulfonamide market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for combination therapies, increasing focus on antimicrobial resistance management, expansion of healthcare access in developing regions, growing applications in agriculture and animal husbandry, and supportive regulatory approvals for sulfonamide formulations. Major trends in the forecast period include advancements in drug delivery technologies, innovations in sulfonamide derivatives, development of targeted antibacterial therapies, ongoing research and development in antimicrobial agents, and integration of artificial intelligence in drug discovery.

The growing prevalence of skin infections is expected to drive the expansion of the sulfonamide market. Skin infections, caused by bacteria, viruses, fungi, or parasites invading the skin, lead to symptoms such as redness, swelling, pain, itching, or pus formation. The rise in skin infections is largely due to the increasing presence of antibiotic-resistant bacteria, making common infections more difficult to treat and more likely to spread. Sulfonamides are effective in treating skin infections by inhibiting bacterial growth and disrupting folic acid synthesis, making them effective against various susceptible bacteria. For example, in February 2025, the American Academy of Dermatology, a U.S.-based nonprofit organization, reported that approximately 50 million Americans suffer from acne each year, making it the most common skin condition in the country. As a result, the increasing prevalence of skin infections is fueling the growth of the sulfonamide market.

Companies in the sulfonamide market are focusing on developing innovative therapies, such as those for primary periodic paralysis (PPP), to expand the therapeutic applications of sulfonamide-based drugs and address unmet needs in rare neuromuscular disorders. PPP therapies are designed to manage a group of rare, inherited neuromuscular disorders that cause episodes of muscle weakness or paralysis triggered by changes in blood potassium levels. For example, in May 2024, Cycle Pharmaceuticals Limited, a U.K.-based pharmaceutical company, introduced ORMALVITM (dichlorphenamide) as a therapy option for patients with hypokalemic periodic paralysis (HypoPP), hyperkalemic periodic paralysis (HyperPP), and similar conditions. This FDA-approved therapy provides a specialized treatment for these genetic disorders, characterized by muscle weakness or paralysis linked to fluctuations in potassium levels. A notable feature of this launch is Cycle's patient-centric approach, which focuses on improving accessibility and adherence through tailored support services.

In June 2023, Shionogi & Company Limited, a Japan-based pharmaceutical company, merged with Qpex Biopharma Inc. to accelerate antibiotic research and development, addressing the growing issue of antimicrobial resistance (AMR). This merger allows Shionogi to enhance its expertise in antibiotic research and AMR by combining its strengths with Qpex Biopharma's innovative compounds and networks, speeding up the development of vital pharmaceuticals. Qpex Biopharma Inc. is a U.S.-based company focused on creating novel anti-infective therapies, particularly those targeting drug-resistant infections.

Major players in the sulfonamide market are Abbott Laboratories, Novartis AG, Teva Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals LLC, Lupin Limited, Bimeda Holdings PLC, Fera Science Limited, Virchow Laboratories Limited, Hebei Veyong Bio-Chemical Co. Ltd., Interchemie Werken De Adelaar B.V., AdvaCare Pharma, Manus Aktteva Biopharma LLP, Suleshvari Pharma, Shree Vardayini Chemical Industries Private Limited, VetOne, Zydus Cadila Healthcare Limited, Mission Pharmacal Company, Allegis Pharmaceuticals LLC.

North America was the largest region in the sulfonamide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sulfonamide report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sulfonamide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sulfonamide market consists of sales of sulfamethoxazole, sulfadiazine, furosemide, and thiazide diuretics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sulfonamide Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sulfonamide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sulfonamide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sulfonamide market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Oral Sulfonamides; Topical Sulfonamides; Injectable Sulfonamides
• 2) By Chemical Structure: Sulfanilamide; Sulfacetamide; Sulfamethoxazole
• 3) By Application: Antibacterial; Antifungal; Antiviral; Diuretics; Antidiabetic; Other Applications
• 4) By End-User: Hospitals; Clinics; Research Laboratories; Other End Users
• Subsegments:
• 1) By Oral Sulfonamides: Sulfamethoxazole; Sulfisoxazole; Sulfadiazine; Sulfalene
• 2) By Topical Sulfonamides: Sulfacetamide Sodium; Silver Sulfadiazine; Sulfamylon; Sulfadiazine Cream
• 3) By Injectable Sulfonamides: Sulfamethoxazole; Sulfadiazine Sodium; Sulfamethoxypyridazine
• Companies Mentioned: Abbott Laboratories; Novartis AG; Teva Pharmaceutical Industries Limited; Intas Pharmaceuticals Limited; Cadila Pharmaceuticals Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sulfonamide Market Characteristics

3. Sulfonamide Market Trends And Strategies

4. Sulfonamide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sulfonamide Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sulfonamide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sulfonamide Market Growth Rate Analysis
• 5.4. Global Sulfonamide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sulfonamide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sulfonamide Total Addressable Market (TAM)

6. Sulfonamide Market Segmentation

• 6.1. Global Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Sulfonamides
• Topical Sulfonamides
• Injectable Sulfonamides
• 6.2. Global Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfanilamide
• Sulfacetamide
• Sulfamethoxazole
• 6.3. Global Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibacterial
• Antifungal
• Antiviral
• Diuretics
• Antidiabetic
• Other Applications
• 6.4. Global Sulfonamide Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Laboratories
• Other End Users
• 6.5. Global Sulfonamide Market, Sub-Segmentation Of Oral Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfamethoxazole
• Sulfisoxazole
• Sulfadiazine
• Sulfalene
• 6.6. Global Sulfonamide Market, Sub-Segmentation Of Topical Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfacetamide Sodium
• Silver Sulfadiazine
• Sulfamylon
• Sulfadiazine Cream
• 6.7. Global Sulfonamide Market, Sub-Segmentation Of Injectable Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfamethoxazole
• Sulfadiazine Sodium
• Sulfamethoxypyridazine

7. Sulfonamide Market Regional And Country Analysis

• 7.1. Global Sulfonamide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sulfonamide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sulfonamide Market

• 8.1. Asia-Pacific Sulfonamide Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sulfonamide Market

• 9.1. China Sulfonamide Market Overview
• 9.2. China Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sulfonamide Market

• 10.1. India Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sulfonamide Market

• 11.1. Japan Sulfonamide Market Overview
• 11.2. Japan Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sulfonamide Market

• 12.1. Australia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sulfonamide Market

• 13.1. Indonesia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sulfonamide Market

• 14.1. South Korea Sulfonamide Market Overview
• 14.2. South Korea Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sulfonamide Market

• 15.1. Western Europe Sulfonamide Market Overview
• 15.2. Western Europe Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sulfonamide Market

• 16.1. UK Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sulfonamide Market

• 17.1. Germany Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sulfonamide Market

• 18.1. France Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sulfonamide Market

• 19.1. Italy Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sulfonamide Market

• 20.1. Spain Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sulfonamide Market

• 21.1. Eastern Europe Sulfonamide Market Overview
• 21.2. Eastern Europe Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sulfonamide Market

• 22.1. Russia Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sulfonamide Market

• 23.1. North America Sulfonamide Market Overview
• 23.2. North America Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sulfonamide Market

• 24.1. USA Sulfonamide Market Overview
• 24.2. USA Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sulfonamide Market

• 25.1. Canada Sulfonamide Market Overview
• 25.2. Canada Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sulfonamide Market

• 26.1. South America Sulfonamide Market Overview
• 26.2. South America Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sulfonamide Market

• 27.1. Brazil Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sulfonamide Market

• 28.1. Middle East Sulfonamide Market Overview
• 28.2. Middle East Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sulfonamide Market

• 29.1. Africa Sulfonamide Market Overview
• 29.2. Africa Sulfonamide Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sulfonamide Market, Segmentation By Chemical Structure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sulfonamide Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sulfonamide Market Competitive Landscape And Company Profiles

• 30.1. Sulfonamide Market Competitive Landscape
• 30.2. Sulfonamide Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Cadila Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

31. Sulfonamide Market Other Major And Innovative Companies

• 31.1. Amneal Pharmaceuticals LLC
• 31.2. Lupin Limited
• 31.3. Bimeda Holdings PLC
• 31.4. Fera Science Limited
• 31.5. Virchow Laboratories Limited
• 31.6. Hebei Veyong Bio-Chemical Co. Ltd.
• 31.7. Interchemie Werken De Adelaar B.V.
• 31.8. AdvaCare Pharma
• 31.9. Manus Aktteva Biopharma LLP
• 31.10. Suleshvari Pharma
• 31.11. Shree Vardayini Chemical Industries Private Limited
• 31.12. VetOne
• 31.13. Zydus Cadila Healthcare Limited
• 31.14. Mission Pharmacal Company
• 31.15. Allegis Pharmaceuticals LLC

32. Global Sulfonamide Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sulfonamide Market

34. Recent Developments In The Sulfonamide Market

35. Sulfonamide Market High Potential Countries, Segments and Strategies

• 35.1 Sulfonamide Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sulfonamide Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sulfonamide Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer